BigHat Biosciences

BigHat Biosciences

Designing transformative therapeutics by integrating frontier AI with autonomous generation of gold-standard data

Location
—
Roles tracked
0
In pipeline
0
Tracking since
—

At a glance

You're tracking 0 roles at BigHat Biosciences. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Biotechnology Research
Company size
98 people
Headquarters
San Mateo, California
Founded
2019
Type
Privately Held
Total funding
$174.3M

BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases. BigHat is backed by Section 32, ‍Andreessen Horowitz, 8VC, Amgen Ventures, Bristol Myers Squibb, Quadrille, Grids Capital, AME Cloud Ventures, Innovation Endeavors and Gaingels.

Artificial Intelligence Artificial Intelligence (AI) Biotechnology Life Science Medical Pharmaceutical Therapeutics Biotech & Pharmaceuticals Pharmaceutical and biotechnology

Open roles at BigHat Biosciences